Creating an artificial deadline around a non-binary event. First, Leo is under no obligation to PR the BTD the day after he receives notice. It makes more sense to hold off until he and other management fully analyze and understand its fullest meaning, perhaps a week or two. Second, the lack of BTD doesn’t mean the inability to move into Phase 3. It only means the FDA will not be as intensely involved in the study.
News 
Market Data 
Discover 
